Insmed Aktie
					
						
							144,00
						
						EUR
					
					
						
							+1,00
						
						EUR
					
					
						
							+0,70
						
						%
					
				
				
				
					
						
							195,81
						
						USD
					
					
						
							+1,39
						
						USD
					
					
						
							+0,71
						
						%
					
				
				
		
		
		
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                Insmed Aktie Analyse
| 09.04.19 | Insmed Buy | H.C. Wainwright & Co. | |
| 02.01.19 | Insmed Buy | Canaccord Adams | |
| 11.07.17 | Insmed Outperform | Robert W. Baird & Co. Incorporated | |
| 15.03.16 | Insmed Buy | Stifel, Nicolaus & Co., Inc. | |
| 09.11.15 | Insmed Neutral | UBS AG | |
| 06.10.15 | Insmed Buy | H.C. Wainwright & Co. | 
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                
                            
        Werbung
    
                        
                            
                                
                            
                        
                    
                 
                                